Nutriband Inc Market Cap ($70.50 Million)
Market Cap & Net Worth: Nutriband Inc (NTRB)
Nutriband Inc market cap. Nutriband Inc (NASDAQ:NTRB) has a market capitalization of $70.50 Million ($70.50 Million) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #20373 globally and #4650 in its home market, demonstrating a 5.36% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nutriband Inc's stock price $6.29 by its total outstanding shares 12155683 (12.16 Million). Also see NTRB cash generation efficiency for how efficiently the company converts equity into cash flow.
Nutriband Inc Market Cap History (2017–2026)
Nutriband Inc market cap history from 2017 to 2026. Data shows growth from $68.77 Million to $76.46 Million (1.19% CAGR). Check NTRB live share price for real-time trading data and today's change.
Index Memberships
Nutriband Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.00% | #570 of 976 |
|
NASDAQ Composite
IXIC
|
$40.20 Trillion | 0.00% | #1951 of 3165 |
Weight: Nutriband Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Nutriband Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nutriband Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore NTRB net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
37.54x
Nutriband Inc's market cap is 37.54 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $145.87 Million | $245.28K | -$3.33 Million | 594.69x | N/A |
| 2020 | $156.29 Million | $370.65K | -$2.80 Million | 421.66x | N/A |
| 2021 | $105.03 Million | $943.70K | -$3.21 Million | 111.29x | N/A |
| 2022 | $43.82 Million | $1.42 Million | -$8.42 Million | 30.81x | N/A |
| 2023 | $28.20 Million | $2.08 Million | -$4.81 Million | 13.56x | N/A |
| 2024 | $57.25 Million | $2.09 Million | -$5.49 Million | 27.46x | N/A |
| 2025 | $55.19 Million | $2.14 Million | -$10.48 Million | 25.79x | N/A |
| 2026 | $76.46 Million | $2.04 Million | -$8.23 Million | 37.54x | N/A |
Competitor Companies of NTRB by Market Capitalization
Companies near Nutriband Inc in the global market cap rankings as of November 4, 2026. Also see Nutriband Inc total assets for a full breakdown of the balance sheet.
Key companies related to Nutriband Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #368 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #414 globally with a market cap of $68.22 Billion USD ( AU$96.41 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $530.76 |
| #368 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $973.36 |
| #414 | CSL Ltd | AU:CSL | $68.22 Billion | AU$198.72 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $228.44 |
Market Capitalization of Nutriband Inc (2017–2026)
Market capitalization of Nutriband Inc from 2017 to today. Between 2017 and today, Nutriband Inc's market cap moved from $68.77 Million to $ 76.46 Million, with a yearly change of 1.19%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $76.46 Million | +38.55% |
| 2025 | $55.19 Million | -3.61% |
| 2024 | $57.25 Million | +103.02% |
| 2023 | $28.20 Million | -35.64% |
| 2022 | $43.82 Million | -58.28% |
| 2021 | $105.03 Million | -32.80% |
| 2020 | $156.29 Million | +7.14% |
| 2019 | $145.87 Million | -59.06% |
| 2018 | $356.34 Million | +418.18% |
| 2017 | $68.77 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Nutriband Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $70.50 Million USD |
| MoneyControl | $70.50 Million USD |
| MarketWatch | $70.50 Million USD |
| marketcap.company | $70.50 Million USD |
| Reuters | $70.50 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Nutriband Inc
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company… Read more